News und Analysen

Global Water Resources (NASDAQ:GWRS) reported higher first-quarter revenue but swung to a loss as increased depreciation, operating costs and interest expense weighed on results, management said on

Innovative Solutions and Support (NASDAQ:ISSC) reported modest revenue growth for its fiscal second quarter as strength in commercial aerospace and business aviation offset a sharp year-over-year

Capital Southwest (NASDAQ:CSWC) reported what management described as an “outstanding” fiscal 2026, highlighting portfolio growth, stable net asset value, strong dividend coverage and continued

Fermi (NASDAQ:FRMI) executives used the company’s first-quarter 2026 earnings call to outline a reset of its leadership structure, reaffirm the commercial rationale for its Project Matador power

• Is SunPower Stock Ready to Lead the Solar Market?

Canadian Solar (NASDAQ:CSIQ) reported first-quarter 2026 revenue at the high end of its forecast and a stronger-than-expected gross margin, helped

• AeroVironment Touches Down On Value Opportunity

AeroVironment (NASDAQ:AVAV) Chairman, President and CEO Wahid Nawabi said accelerating global security threats are reshaping defense priorities

• 5 Space Stocks Already Climbing Ahead of the SpaceX IPO

Redwire (NYSE:RDW) reported sharply higher first-quarter 2026 revenue and record backlog, while management said the company is increasing

• MarketBeat Week in Review – 9/4 - 9/8

Oshkosh (NYSE:OSK) reported first-quarter 2026 results that came in modestly below its internal expectations, but management maintained its full-year outlook

Octave Specialty Group (NYSE:OSG) reported a narrower first-quarter loss and sharply higher adjusted earnings, driven by rapid growth in its insurance distribution business and contributions from

• 3 Clean Energy Stocks With Bullish Moving Average Signals

Ormat Technologies (NYSE:ORA) reported record first-quarter 2026 revenue and maintained its full-year outlook, as strength in its energy

• 3 small-cap biotechs with potential breakthroughs in 2024

Amylyx Pharmaceuticals (NASDAQ:AMLX) is preparing for a pivotal Phase 3 readout for AVEXITIDE, its lead asset for post-bariatric

Fluent (NASDAQ:FLNT) reported a sharp shift in its business mix in the first quarter of 2026, with management pointing to continued rapid growth in Commerce Media Solutions as the company’s central

KLX Energy Services (NASDAQ:KLXE) reported first-quarter 2026 revenue of $145 million and adjusted EBITDA of $11.1 million, with management describing the period as the likely low point for the

Bilfinger (ETR:GBF) confirmed its 2026 outlook after reporting a slower start to the year, with management pointing to severe winter weather and geopolitical uncertainty as factors that delayed

Abeona Therapeutics (NASDAQ:ABEO) reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with executives highlighting new patient treatments, expanded treatment-center

Avon Protection (LON:AVON) reported a strong first half, with executives saying revenue, profit and returns improved materially as the group’s multi-year transformation program nears completion and

Caris Life Sciences (NASDAQ:CAI) executives said the company is expanding its commercial reach, product pipeline and biopharma partnerships as it looks to build on recent revenue growth following